SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Cue Biopharma Q3 EPS $(0.31) Up From $(0.62) YoY, Sales $984K Up From $449K YoY

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.31) per share. This is a 50 percent increase over losses of $(0.62) per share from the same period last year. The company reported $984 thousand in sales this

Benzinga · -

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.31) per share. This is a 50 percent increase over losses of $(0.62) per share from the same period last year. The company reported $984 thousand in sales this quarter. This is a 119.15 percent increase over sales of $449 thousand the same period last year.